The development of new tools to quantify the many ways that rare diseases like FCS can affect patients is imperative.
Michael W. Stevenson, RPh, PhD
Advertisement
Articles by Michael W. Stevenson, RPh, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD
2
6 Gastroenterology Headlines You Missed in May 2026
3
Q&A: How Lifelong Burdens Are Shaped by Childhood Eczema, With Delphine Kerob, MD
4
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
5